➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

Aurobindo Pharma Ltd Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for AUROBINDO PHARMA LTD, and what generic and branded alternatives to AUROBINDO PHARMA LTD drugs are available?

AUROBINDO PHARMA LTD has three hundred and nine approved drugs.

There are sixteen tentative approvals on AUROBINDO PHARMA LTD drugs.

Summary for Aurobindo Pharma Ltd

Drugs and US Patents for Aurobindo Pharma Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd AZITHROMYCIN azithromycin FOR SUSPENSION;ORAL 209201-002 Oct 9, 2018 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd EFAVIRENZ efavirenz CAPSULE;ORAL 078064-002 Dec 15, 2017 RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd RITONAVIR ritonavir TABLET;ORAL 206614-001 Sep 17, 2018 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd REPAGLINIDE repaglinide TABLET;ORAL 203820-003 Jan 22, 2014 AB RX No Yes   Start Trial   Start Trial
Aurobindo Pharma Ltd METRONIDAZOLE metronidazole TABLET;ORAL 203974-002 May 29, 2015 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for AUROBINDO PHARMA LTD drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.